163 related articles for article (PubMed ID: 19109170)
1. Role of TNF-alpha produced by nonantigen-specific cells in a fulminant hepatitis mouse model.
Ito H; Ando K; Ishikawa T; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
J Immunol; 2009 Jan; 182(1):391-7. PubMed ID: 19109170
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis.
Ohtaki H; Ito H; Ando K; Ishikawa T; Hoshi M; Ando T; Takamatsu M; Hara A; Moriwaki H; Saito K; Seishima M
Biochim Biophys Acta; 2014 Sep; 1842(9):1464-71. PubMed ID: 24768802
[TBL] [Abstract][Full Text] [Related]
3. Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes.
Kasahara S; Ando K; Saito K; Sekikawa K; Ito H; Ishikawa T; Ohnishi H; Seishima M; Kakumu S; Moriwaki H
J Virol; 2003 Feb; 77(4):2469-76. PubMed ID: 12551985
[TBL] [Abstract][Full Text] [Related]
4. Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen.
Ohta A; Sekimoto M; Sato M; Koda T; Nishimura S; Iwakura Y; Sekikawa K; Nishimura T
J Immunol; 2000 Jul; 165(2):956-61. PubMed ID: 10878371
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
Ando K; Moriyama T; Guidotti LG; Wirth S; Schreiber RD; Schlicht HJ; Huang SN; Chisari FV
J Exp Med; 1993 Nov; 178(5):1541-54. PubMed ID: 8228807
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of TNF-alpha by CD8+ type 1 cells and down-regulation of IFN-gamma production by CD4+ Th1 cells contribute to toxic shock-like syndrome in an animal model of fatal monocytotropic ehrlichiosis.
Ismail N; Soong L; McBride JW; Valbuena G; Olano JP; Feng HM; Walker DH
J Immunol; 2004 Feb; 172(3):1786-800. PubMed ID: 14734762
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
8. γδ T cells are indispensable for interleukin-23-mediated protection against Concanavalin A-induced hepatitis in hepatitis B virus transgenic mice.
Meng Z; Wang J; Yuan Y; Cao G; Fan S; Gao C; Wang L; Li Z; Wu X; Wu Z; Zhao L; Yin Z
Immunology; 2017 May; 151(1):43-55. PubMed ID: 28092402
[TBL] [Abstract][Full Text] [Related]
9. Clara Cell 10 kDa Protein Alleviates Murine Hepatitis Virus Strain 3-Induced Fulminant Hepatitis by Inhibiting Fibrinogen-Like Protein 2 Expression.
Yu H; Liu Y; Wang H; Wan X; Huang J; Yan W; Xi D; Luo X; Shen G; Ning Q
Front Immunol; 2018; 9():2935. PubMed ID: 30619295
[No Abstract] [Full Text] [Related]
10. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
[TBL] [Abstract][Full Text] [Related]
11. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice.
Chun E; Lee J; Cheong HS; Lee KY
J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674
[TBL] [Abstract][Full Text] [Related]
12. Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells.
Matter MS; Hilmenyuk T; Claus C; Marone R; Schürch C; Tinguely M; Terracciano L; Luther SA; Ochsenbein AF
PLoS One; 2011; 6(9):e24772. PubMed ID: 21966366
[TBL] [Abstract][Full Text] [Related]
13. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors.
Chen SH; Wu HL; Kao JH; Hwang LH
PLoS One; 2012; 7(5):e36984. PubMed ID: 22615863
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4Ig suppresses liver injury by inhibiting acquired immune responses in a mouse model of fulminant hepatitis.
Nakayama Y; Shimizu Y; Hirano K; Ebata K; Minemura M; Watanabe A; Sugiyama T
Hepatology; 2005 Oct; 42(4):915-24. PubMed ID: 16175605
[TBL] [Abstract][Full Text] [Related]
15. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
Chen Y; Wei H; Sun R; Tian Z
Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
[TBL] [Abstract][Full Text] [Related]
16. Induction of hepatitis B virus surface antigen-specific cytotoxic T lymphocytes can be up-regulated by the inhibition of indoleamine 2, 3-dioxygenase activity.
Ito H; Ando T; Ando K; Ishikawa T; Saito K; Moriwaki H; Seishima M
Immunology; 2014 Aug; 142(4):614-23. PubMed ID: 24580128
[TBL] [Abstract][Full Text] [Related]
17. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
18. HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection.
Loirat D; Mancini-Bourgine M; Abastado JP; Michel ML
Int Immunol; 2003 Oct; 15(10):1125-36. PubMed ID: 13679383
[TBL] [Abstract][Full Text] [Related]
19. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
20. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.
Sette AD; Oseroff C; Sidney J; Alexander J; Chesnut RW; Kakimi K; Guidotti LG; Chisari FV
J Immunol; 2001 Jan; 166(2):1389-97. PubMed ID: 11145724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
